期刊文献+

MicroRNA-21对胆管癌细胞侵袭与转移的影响 被引量:4

Effect of microRNA-21 on invasion and metastasis of cholangiocarcinoma
暂未订购
导出
摘要 目的探讨microRNA-21对胆管癌QBC939细胞株侵袭转移能力的作用。方法构建合成无关序列、microRNA-21 mimics和microRNA-21 inhibitor并转染至胆管癌QBC939细胞中。实验设自然生长组(Cell)、转染无关序列组(Cell-NC)、转染microRNA-21 mimics组(Cell-21M)及转染microRNA-21 inhibitor组(Cell-21I)。运用实时定量RTPCR检测各组细胞microRNA-21的表达;通过黏附实验检测各组细胞聚集能力的变化;划痕实验、Transwell迁移观察细胞迁移能力变化,Transwell侵袭实验观察细胞侵袭能力变化。结果与Cell组相比,microRNA-21在Cell-NC组表达无明显差异,在Cell-21M组表达增加,在Cell-21I组表达降低。黏附实验显示:与Cell组相比,Cel-NC组细胞聚集能力无明显变化,Cell-21M组细胞聚集能力增强,Cell-21I组细胞聚集能力减弱(P<0.05);划痕实验及Transwell迁移实验示Cell-NC组细胞迁移能力无明显变化,Cell-21M组细胞迁移能力增强,Cell-21I细胞聚集能力减弱(P<0.05);Transwell侵袭实验示Cell-NC组细胞侵袭能力无明显变化,Cell-21M组细胞侵袭能力增强,Cell-21I细胞侵袭能力减弱(P<0.05)。结论 microRNA-21可增强胆管癌QBC939细胞的侵袭与转移能力,提示microRNA-21可能在胆管癌的侵袭转移过程中发挥重要作用。 Objective To detect the effects of microRNA-21 on invasion and metastasis of cholangiocarcinoma QBC939 cells. Methods MicroRNA-21 scamble, mimics and inhibitor were constructed and transfected into QBC939 cells. The blank control gruop( Cell) ,negative control group( Cell-NC) ,micorRNA-21 mimics group( Cell-21M)and microRNA-21 inhibitor group(Cell-21I)were designed in this study. The expression of microRNA-21 was examined by real-time RT-PCR. Then adhesion experiment was used to examin aggregation capability. Wound healing experiment and transwell migration experiment were used to investigate the the migration capability. Tran-swell invasion experiment was used to investigate the invasion capability of cells in each group. Results Compa-ring with Cell, the expression of microRNA-21 in Cell-21M was added and in Cell-21I was reduced. Adhesion ex-periment showed that aggregation capability of cells in Cell-21 M was increased and in Cell-21 I decreased ( P &lt;0.05 ) . Wound healing experiment and transwell migration experiment showed that migration capability of cells in Cell-21 M was increased and in Cell-21 I decreased ( P&lt;0.05 ) . Transwell invasion experiment showed that invasion capability of cells in Cell-21 M was increased and in Cell-21 I decreased ( P&lt;0.05 ) . All the results had no differ-ent significance in Cell-NC. Conclusion MicroRNA-21 can promote the invasion and metastasis of cholangiocarci-noma QBC939 cells, which suggest that microRNA-21 may play a vital role in the process of invasion and metastasis of cholangiocarcinoma.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第2期190-193,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金(编号:1208085mh176)
关键词 胆管癌 MICRORNA-21 侵袭 转移 MICRORNA-21 cholangiocarcinoma metastasis invasion
  • 相关文献

参考文献12

  • 1Friman S. Cholangiocarcinoma-current treatment options[J].Scand J Surg,2011,(1):30-34.
  • 2刘磊,刘臣海,黄强,谢放,邵峰.胆管癌组织中microRNA-21的表达与上皮间质转化的关系及对预后评估的价值[J].中华消化外科杂志,2013,12(3):228-232. 被引量:13
  • 3Schanen B C,Li X. Transcriptional regulation of mammalian miR-NA genes[J].{H}GENOMICS,2011,(1):1-6.
  • 4Jansson M D,Lund A H. MicroRNA and cancer[J].Mol Oncol,2012,(6):590-610.
  • 5项茹,吴正升,张晴,徐晓春,吴强.miR-133a在乳腺癌组织中的表达及其临床意义[J].安徽医科大学学报,2011,46(2):109-112. 被引量:7
  • 6Hiyoshi Y,Kamohara H. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma[J].{H}Clinical Cancer Research,2009,(6):1915-1922.
  • 7Li T,Li D,Sha J,Sun P. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in pros-tate cancer cells[J].{H}Biochemical and Biophysical Research Communications,2009,(3):280-285.
  • 8Zhang J G,Wang J J,Zhao F. MicroRNA-21(miR-21)represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer(NSCLC)[J].{H}Clinica Chimica Acta,2010,(11-12):846-852.
  • 9Zhang B G,Li J F,Yu B Q. microRNA-21 promotes tumor prolif-eration and invasion in gastric cancer by targeting PTEN[J].On-col Rep,2012,(4):1019-1026.
  • 10Negrini M,Gramantieri L,Sabbioni S. microRNA involve-ment in hepatocellular carcinoma[J].Anticancer Agents Med Chem,2011,(6):500-521.

二级参考文献18

  • 1Schickel R,Boyerinas B,Park S M,et al.MicroRNAs:key players in the immune system,differentiation,tumorigenesis and cell death[J].Oncogene,2008,27(45):5959-74.
  • 2Chiyomaru T,Enokida H,Tatarano S,et al.miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer[J].Br J Cancer,2010,102(5):883-91.
  • 3Tavassoli F A,Devilee P.World Health Organization Classification of Tumours.Pathology and genetics of tumours of the breast and female genital organs[M].IARC Press Lyon,2003:19-109.
  • 4Wolff A C,Hammond M E,Schwartz J N,et al.American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].J Clin Oncol,2007,25(1):118-45.
  • 5Lagos-Quintana M,Rauhut R,Lendeckel W,et al.Identification of novel genes coding for small expressed RNAs[J].Science,2001,294(5543):853-8.
  • 6Arndt G M,Dossey L,Cullen L M,et al.Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer[J].BMC Cancer,2009,9(1):374.
  • 7Iorio M V,Ferracin M,Liu C G,et al.MicroRNA gene expression deregulation in human breast cancer[J].Cancer Res,2005,65(16):7065-70.
  • 8Bartel D P.MicroRNAs:genomics,biogenesis,mechanism,and function[J].Cell,2004,116(2):281-97.
  • 9Wong T S,Liu X B,Chung-Wai Ho A,et al.Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling[J].Int J Cancer,2008,123(2):251-7.
  • 10Ichimi T,Enokida H,Okuno Y,et al.Identification of novel microRNA targets based on microRNA signatures in bladder cancer[J].Int J Cancer,2009,125(2):345-52.

共引文献18

同被引文献51

  • 1Apaporn Menakongka,Tuangporn Suthiphongchai.Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion[J].World Journal of Gastroenterology,2010,16(6):713-722. 被引量:33
  • 2Friman S. Cholangiocarcinoma-current treatment options [ J ]. Scand J Surg,2011,100(1) :30 -4.
  • 3Xu J, Wu C, Che X, et al. Circulating microRNAs, miR-21, miR- 122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis[J]. Mol Carcinog,2011,50(2) :136 -42.
  • 4Asaga S, Kuo C, Nguyen T, et al. Direct serum assay for microR- NA-21 concentrations in early and advanced breast cancer [J]. Clin Chem, 2011,57 ( 1 ) : 84 - 91.
  • 5Richmond P J, Karayiannakis A J, Nagafuchi A, et al. Aberrant E- cadherin and alpha-catenin expression in prostate cancer: correla- tion with patient survival [ J ]. Cancer Res, 1997,57 (15) :3189 -93.
  • 6Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epi- thelia- mesenchymal transition in pancreatic carcinoma [ J ]. Clin Cancer Res,2004,10( 12 Pt 1 ) :4125 -33.
  • 7Dang Y, Yu J, Ng S S. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. [ J]. Cancer Manag Res,2014,6: 405 - 22.
  • 8Zhang B G,Li J F,Yu B Q. microRNA-21 promotes tumor prolifer- ation and invasion in gastric cancer by targeting PTEN [ J ]. Oncol Rep ,2012,27 (4) : 1019 - 26.
  • 9Zheng J, Xue H, Wang T, et al. miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and in- vasion[ J]. J Cell Biochem ,2011,112 (3) :872 - 80.
  • 10Krantz S B, Shields M A, Dangi-Garimella S, et al. Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pan- creatic cancer progression[J]. J Surg Res, 2012,173 ( 1 ) : 105 - 12.

引证文献4

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部